SCHEMBL5221778

SCHEMBL5221778

CCNc1cc(C(=O)OC)c(F)c(N2CCCS2(O)O)c1

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 7/20 0.41
BACE2 Q9Y5Z0 5/20 0.41
CTSD P07339 4/20 0.41
CYP3A4 P08684 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
GAA P10253 3/20 0.34
ALOX15 P16050 3/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 1/20 0.32
MAPT P10636 1/20 0.31
CYP1A2 P05177 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219939 0.97 BACE1 (0.43) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221774 0.89 BACE1 (0.49) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5223182 0.89 BACE1 (0.40) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5219943 0.86 BACE1 (0.53) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5220629 0.85 BACE1 (0.43) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5221780 0.82 CTSD (0.34) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5226788 0.81 OPRK1 (0.35)
SCHEMBL5223868 0.81 CTSD (0.34) BACE1BACE2CTSDCYP3A4CYP2D6
SCHEMBL5224678 0.79 PTGS2 (0.34) ALDH1A1HSD17B10
SCHEMBL5224671 0.79 PTGS2 (0.34) ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed